Threshold limit values of the antiviral drug interferon inducer amixin in the air of the working area and in the atmospheric air of urban and rural settlements
- Authors: Golubeva M.I.1, Bidevkina M.V.2, Bobrineva I.A.1, Fedorova E.A.1
-
Affiliations:
- Joint-Stock Company «All-Union Scientific Center for the Safety of Biologically Active Compounds» (JSC «VNC BAV»)
- F.F. Erisman Federal Scientific Hygiene Center of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing
- Issue: No 2 (2022)
- Pages: 122-127
- Section: New information about toxicity and danger
- Published: 21.04.2022
- URL: https://rjsvd.com/0869-7922/article/view/641443
- DOI: https://doi.org/10.47470/0869-7922-2022-30-2-122-127
- ID: 641443
Cite item
Full Text
Abstract
Introduction. Amiksin (tiloron) is a low molecular weight inducer of interferon, antiviral and immunomodulatory agent, used for the treatment and prevention of viral diseases, shown the effectiveness of including amixin in the complex therapy of SARS-CoV-2 infection (COVID-19) mild and moderate severity.
Materials and methods. Experimental studies to determine the parameters of amixin toxicometry were carried out using mice, rats, rabbits and guinea pigs. The substance was administered into the stomach, intraperitoneally, into the conjunctival sac of the eye, on the skin, intradermal and inhalation.
Results. It is shown that amixin belongs to the 3rd hazard class (moderately hazardous substances) when injected into the stomach according to GOST 12.1.007-76: DL50 for male mice — 500 mg/kg, for female mice — 760 mg/kg; low toxicity when injected into the abdominal cavity, DL50 for male mice — 150 mg/kg. Amiksin has a weak irritant effect on the mucous membranes of the eyes, does not irritate the skin, has a skin-resorptive effect and functional cumulative activity. The threshold for acute inhalation exposure to amixin is set at 16,2 mg/m3 according to the effect on the functional state of the liver and kidneys.
Limitations. When developing and substantiating the hygienic standards for amixin in the air, various ways of the substance entering the body of several animal species in representative groups were studied.
Conclusion. For amixin aerosol, hygienic standards have been approved — 0,4 mg/m3 in the air of the working area and 0,01 mg/m3 in the atmospheric air.
Keywords
About the authors
Margarita Ivanovna Golubeva
Joint-Stock Company «All-Union Scientific Center for the Safety of Biologically Active Compounds» (JSC «VNC BAV»)
Author for correspondence.
Email: golubevamargo@mail.ru
ORCID iD: 0000-0002-0516-750X
Head of the Laboratory of Preventive Toxicology and Hygiene JSC “VNС BAV», 142450, Staraya Kupavna, Moscow region, Russian Federation.
e-mail: golubevamargo@mail.ru
Russian FederationMarina Vasilevna Bidevkina
F.F. Erisman Federal Scientific Hygiene Center of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing
Email: mbidevkina@mail.ru
ORCID iD: 0000-0003-4319-7192
Доктор медицинских наук, заведующая отделом токсикологии Института дезинфектологии ФБУН «ФНЦГ им. Ф.Ф. Эрисмана» Роспотребнадзора, г. Москва.
e-mail: mbidevkina@mail.ru
Russian FederationIrina Alekseevna Bobrineva
Joint-Stock Company «All-Union Scientific Center for the Safety of Biologically Active Compounds» (JSC «VNC BAV»)
Email: ural955@mail.ru
Ведущий научный сотрудник лаборатории профилактической токсикологии и гигиены АО «ВНЦ БАВ», г. Старая Купавна Московской обл.
e-mail: ural955@mail.ru
Russian FederationEmma Alexeevna Fedorova
Joint-Stock Company «All-Union Scientific Center for the Safety of Biologically Active Compounds» (JSC «VNC BAV»)
Email: emfed@mail.ru
Старший научный сотрудник лаборатории профилактической токсикологии и гигиены АО «ВНЦ БАВ», г. Старая Купавна Московской обл.
e-mail: emfed@mail.ru
Russian FederationReferences
- Grigoryan S.S., Isaeva E.I., Bakalov V.V., Osipova E.A., Bevz A.Yu., Prostyakov I.V., Nadorov S.A. Amixin – induction of interferons alpha, beta, gamma and lambda in blood serum and lung tissue. RMZH. 2015; 23(2): 93-9. (in Russian)
- Krueger R.F., Mayer G.D. Tilorone hydrochloride: an orally active antiviral agent. Science. 1970; 169: 1213–4.
- Kalyuzhin O.V. Tilorone as a chosen preparation for prevention and treatment of acute respiratory viral infections. Lechashchiy vrach. 2013; 10: 43-8. (in Russian)
- Gluhovskoj D.V., Emelyanova K.E. The use of Tiloron as part of complex therapy in patients with a mild form of COVID-19. FGBVOU VO [Primenenie Tilorona v sostave kompleksnoj terapii u bolnyh legkoj formoj COVID-19]. FGBVOU VO «Voenno-medicinskaya akademiya imeni S.M. Kirova» MO RF g. Sankt Peterburg. Rossiya. Available at: https://tiloron-sz.ru/primenenie-tilorona-sz-v-sostave-kompleksnoj-terapii-u-bolnyh-legkoj-formoj-covid-19 (in Russian)
- Рermyakova O.V., Popova A.Yu., Ovchinnikov R.I. Approbation of the results of the use of the drug Tiloron-C3 125 mg in infection caused by the SARS-CoV-2 virus in a new coronavirus infection (COVID-19) [Aprobaciya rezul`tatov primeneniya preparata Tiloron-S3 125 mg pri infekcii, vy`zvannoj virusom SARS-CoV-2 pri novoj koronavirusnoj infekcii (SOVID-19)]. FGBU «Nacionalnyj medicinskij issledovatelskij centr akusherstva ginekologii i perinatologii im akad V.I. Kulakova» Minzdrava GBUZ «KDP No. 121 DZM». Available at: https://www.vidal.ru/vracham/vracham-obschei-praktiki/klinicheskie-issledovanija/aprobatsiia-rezultatov-primeneniia-preparata-tiloron-s3-125-mg-pri-infektsii-vyzvannoy-virusom-sars-cov-2 (in Russian)
- Sangeun Jeon, Meehyun Ko, Jihye Lee, Inhee Choi, Soo Young Byun, Soonju Park et al. Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs. Antimicrobial Agents and Chemotherapy; July 2020, 64 (Issue 7), р 1-9.
- SanPiN 1.2.3685-21 “Hygienic standards and requirements for ensuring the safety and (or) harmlessness of environmental factors for humans”. Moscow; 2021. (in Russian)
Supplementary files
